Symptom monitoring with electronic patient-reported outcomes during treatment for metastatic cancer: Survival and hospitalization results from the PRO-TECT trial (Alliance AFT-39)
   Google Scholar   
Citation:
Ann Oncol vol 34 (suppl 2) S1078, abstr 2030O
Meeting Instance:
ESMO 2023
Year:
2023
Type:
Abstract
Sub type:
Oral
Funding:
AFT PCORI
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Parents:
None
Children:
4346  
Program:
CCP
Primary Committee:
CCDR
Sec. Committees:
Health Outcomes    
Pharmas:
 
Grants:
IHS-1511-33392  
Corr. Author:
 
Authors:
                                         
Networks:
LAPS-IL036, LAPS-MN026, LAPS-NC007, LAPS-NC010, LAPS-NY016, NY167   
Study
AFT-39
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: